Possible role of dimerization in human immunodeficiency virus type 1 genome RNA packaging. 2003

Jun-Ichi Sakuragi, and Shigeharu Ueda, and Aikichi Iwamoto, and Tatsuo Shioda
Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Suita City, Japan. sakuragi@biken.osaka-u.ac.jp

The dimer initiation site/dimer linkage sequence (DIS/DLS) region in the human immunodeficiency virus type 1 (HIV-1) RNA genome is suggested to play important roles in various steps of the virus life cycle. However, due to the presence of a putative DIS/DLS region located within the encapsidation signal region (E/psi), it is difficult to perform a mutational analysis of DIS/DLS without affecting the packaging of RNA into virions. Recently, we demonstrated that duplication of the DIS/DLS region in viral RNA caused the production of partially monomeric RNAs in virions, indicating that the region indeed mediated RNA-RNA interaction. We utilized this system to assess the precise location of DIS/DLS in the 5' region of the HIV-1 genome with minimum effect on RNA packaging. We found that the entire lower stem of the U5/L stem-loop was required for packaging, whereas the region important for dimer formation was only 10 bases long within the lower stem of the U5/L stem-loop. The R/U5 stem-loop was required for RNA packaging but was completely dispensable for dimer formation. The SL1 lower stem was important for both dimerization and packaging, but surprisingly, deletion of the palindromic sequence at the top of the loop only partially affected dimerization. These results clearly indicated that the E/psi of HIV-1 is much larger than the DIS/DLS and that the primary DIS/DLS is completely included in the E/psi. Therefore, it is suggested that RNA dimerization is a part of RNA packaging, which requires multiple steps.

UI MeSH Term Description Entries
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

Jun-Ichi Sakuragi, and Shigeharu Ueda, and Aikichi Iwamoto, and Tatsuo Shioda
October 2004, Journal of virology,
Jun-Ichi Sakuragi, and Shigeharu Ueda, and Aikichi Iwamoto, and Tatsuo Shioda
June 1992, Virology,
Jun-Ichi Sakuragi, and Shigeharu Ueda, and Aikichi Iwamoto, and Tatsuo Shioda
February 2002, Journal of virology,
Jun-Ichi Sakuragi, and Shigeharu Ueda, and Aikichi Iwamoto, and Tatsuo Shioda
May 1991, Nucleic acids research,
Jun-Ichi Sakuragi, and Shigeharu Ueda, and Aikichi Iwamoto, and Tatsuo Shioda
December 1996, Journal of virology,
Jun-Ichi Sakuragi, and Shigeharu Ueda, and Aikichi Iwamoto, and Tatsuo Shioda
July 1998, Journal of virology,
Jun-Ichi Sakuragi, and Shigeharu Ueda, and Aikichi Iwamoto, and Tatsuo Shioda
October 1995, Journal of virology,
Jun-Ichi Sakuragi, and Shigeharu Ueda, and Aikichi Iwamoto, and Tatsuo Shioda
December 2002, Journal of virology,
Jun-Ichi Sakuragi, and Shigeharu Ueda, and Aikichi Iwamoto, and Tatsuo Shioda
May 2002, Journal of virology,
Copied contents to your clipboard!